摘要
目的:探讨小鼠造血系干祖细胞表面标志c-Kit在急性早幼粒细胞白血病(APL)起始细胞中的作用。方法:以人源移动抑制因子相关蛋白8基因启动子表达的人源早幼粒细胞白血病-维A酸受体α融合基因(hMRP8-hPML-RAR)转基因所致小鼠APL为研究模型,研究APL起始细胞的表面标志。结果:发现在APL小鼠模型体内存在一群以c-Kit+为标志的白血病起始细胞(LIC)。通过体外培养,发现LIC在失去肿瘤微环境支持后由c-Kit+细胞向c-Kit-细胞分化,同时逐渐丧失白血病致病力。c-Kit的磷酸化位点抑制剂伊马替尼和小发夹RNA(shRNA)虽均抑制c-Kit功能和(或)表达,但并不能明显影响白血病致病力。结论:肿瘤微环境在APL起始细胞致瘤力的维持上有非常重要的作用,在白血病致病力的维持上c-Kit可能并不是一主导功能因素。
Objective: To investigate the role of c-Kit, a surface marker of mouse hematopoietic stem/progenitor cells, in acute promyelocytie leukemia-initiating cells (LIC). Methods: Mouse acute promyelocytic leukemia (APL) constructed transgenically by human promyelocytie leukemia-retinoic acid receptor (hMRP8-hPML-RAR)expressed by promoter of human migration inhibitory factor-related protein 8 gene was used as the investigating model. Results: There was a subset of c-Kit LIC, and it was differentiated into c-Kit- subset during in vitro culture without tumor micro-environmental support and lost its leukemia initiating ability, c-Kit phosphorylation site inhibitor imatinib and knockdown of c-Kit expression by short hairpin RNA (shRNA) had no effect on leukemia initiating ability. Conclusions: These results suggested that tumor microenvironment played an important role in the maintenance of leukemia initiating ability, and c-Kit might not be a key factor in maintaining the leukemia initiating ability.
出处
《内科理论与实践》
2012年第3期210-213,共4页
Journal of Internal Medicine Concepts & Practice